top of page
Senior Patient

Patients are our priority, designing curative medicines is our mission

Our primary focus is patients suffering from currently incurable life altering diseases. The disruptive PRISM™ Platform is a leading-edge novel physics-based drug design engine that has resulted in a pipeline of clinic-ready assets for the treatment of diseases across multiple clinical areas including neurology, oncology, and infectious disease.

News & Press Releases

Solving the Most Challenging Diseases
Asha's Therapeutic Focus Areas


Neurology & Neurodegneration

Alzheimer's Disease | Parkinson's Disease | ALS

Asha's Solution: ASHA-091 & ASHA-624


Oncology & Immuno-oncology

Colorectal Cancer | Hepatocellular Carcinoma | Melanoma

Asha's Solution: ASHA-044


Infectious Disease & Post-viral Illness

ME/CFS | Long COVID | Antibiotic Resistance

Asha's Solution: ASHA-091 & Undisclosed

A Revolutionary & Paradigm Shifting Technology
The PRISM™ Design Platform

Central to Asha's efforts to identify and drug difficult to hit targets with high disease relevance is our proprietary novel physics-based drug design platform, PRISM™

Partner with us to leverage the power of 
The PRISM™ Design Platform 
to solve your targets of interest

PRISM Puzzle.tif
bottom of page